<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250928067398N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-10-01</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effects of two different treatments on attention and behavior control in defiant children</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of a multidimensional intervention (transcranial direct current stimulation and skill-based cognitive-behavioral intervention) on response inhibition and attentional bias to threat in children with oppositional defiant disorder</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-10-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>45</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/86466</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Crossover, Purpose: Treatment, Randomization description: Randomization method: Simple randomization
Unit of randomization: Individual
Randomization tool: SPSS software (random number generation)
Sequence generation: Participants allocated equally across groups based on random numbers generated
Block/stratified randomization: Not applied (small sample, homogeneous population).</study_design>
      <phase>N/A</phase>
      <hc_freetext>Oppositional Defiant Disorder (ODD).</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intervention Group 1 (Transcranial Direct Current Stimulation – tDCS):Participants in this group received nine sessions of transcranial direct current stimulation (tDCS), three sessions per week for three consecutive weeks. Each session lasted approximately 20 minutes. A 2 mA direct current was applied using saline-soaked sponge electrodes with anodal placement over the left DLPFC and cathodal over the right DLPFC. The device used was CE certified and approved by the Ministry of Health. Intervention 2: Intervention group: Intervention Group 2 (Cognitive-Behavioral Skill-Based Intervention – CBT):Participants attended nine weekly training sessions (each lasting about 70 minutes). The sessions included emotional regulation, anger management, effective communication, and problem-solving skills. The intervention was delivered by the researcher under supervisor supervision using standard cognitive-behavioral techniques. Intervention 3: Control group: Participants in this group did not receive any intervention during the study period. They only participated in the pre-test and post-test assessments. After the completion of the study, optional educational sessions were provided to the control group to ensure ethical considerations.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Since the individual participant data are confidential and specific to a master’s thesis, public sharing is not recommended.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Elnaz Nazer</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 2, Unit 4, Sabzeh Alley, 73rd Square, Janbazan Gharbi St., Narmak District, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1648944963   				  	</zip>
        <telephone>+98 21 7793 9218</telephone>
        <email>elinazer2@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Elnaz Nazer</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 2, Unit 4, Sabzeh Alley, 73rd Square, Janbazan Gharbi St., Narmak District, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1648944963   				  	</zip>
        <telephone>+98 21 7793 9218</telephone>
        <email>elinazer2@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosis of oppositional defiant disorder (ODD) by a psychiatrist or clinical psychologist based on DSM-5 criteria
Written informed consent from parents for child participation
Ability to attend intervention sessions and complete the required tasks
Absence of severe comorbid disorders such as autism spectrum disorder or intellectual disability
No regular use of psychiatric medications during the past three months</inclusion_criteria>
      <agemin>8 years</agemin>
      <agemax>12 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Neurological disorders or epilepsy interfering with tDCS intervention
Any medical contraindication for receiving transcranial direct current stimulation</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F91.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Oppositional defiant disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Behavior</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention Group 1 (Transcranial Direct Current Stimulation – tDCS):Participants in this group received nine sessions of transcranial direct current stimulation (tDCS), three sessions per week for three consecutive weeks. Each session lasted approximately 20 minutes. A 2 mA direct current was applied using saline-soaked sponge electrodes with anodal placement over the left DLPFC and cathodal over the right DLPFC. The device used was CE certified and approved by the Ministry of Health.</i_keyword>
      <i_keyword>Intervention group: Intervention Group 2 (Cognitive-Behavioral Skill-Based Intervention – CBT):Participants attended nine weekly training sessions (each lasting about 70 minutes). The sessions included emotional regulation, anger management, effective communication, and problem-solving skills. The intervention was delivered by the researcher under supervisor supervision using standard cognitive-behavioral techniques.</i_keyword>
      <i_keyword>Control group: Participants in this group did not receive any intervention during the study period. They only participated in the pre-test and post-test assessments. After the completion of the study, optional educational sessions were provided to the control group to ensure ethical considerations.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Response Inhibition:This variable assesses participants’ ability to inhibit impulsive responses and control behavioral reactions. It is evaluated using the computerized Stroop Color-Word Test. The main indicators are the number of correct responses, number of errors, and reaction time (in milliseconds). Decreased reaction time and error rate, along with increased accuracy, indicate improvement in response inhibition. Timepoint: Pre-test (before intervention) and Post-test (after completion of intervention sessions). Method of measurement: Response inhibition is measured using the computerized Stroop Color-Word Task. The stimuli consist of congruent and incongruent color-word pairs, and participants must identify the color of the word while ignoring its meaning. Reaction time (in milliseconds) and accuracy of responses are recorded as the main indicators.</prim_outcome>
      <prim_outcome>Attention Bias to Threat:This variable measures participants’ tendency to allocate attention toward threatening stimuli. It is assessed using the Dot-Probe Task involving pairs of emotional (angry, fearful, disgusted) and neutral facial images. Reaction time to the location of the probe appearing after the image pair is recorded. Reduced reaction time to threatening stimuli indicates decreased attention bias to threat. Timepoint: Pre-test (before intervention) and Post-test (after completion of intervention sessions). Method of measurement: Attention bias to threat is measured using the Dot-Probe Task. Participants view pairs of emotional (threat-related) and neutral faces and respond to the location of a probe appearing immediately after. The difference in reaction times between threat and neutral stimuli is calculated as the index of attention bias.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The mean reaction time and accuracy rate of participants in the congruent and incongruent conditions of the Stroop task are measured separately. Reduced reaction time and increased accuracy in both conditions indicate improvement in cognitive processing and attentional control. Timepoint: Pre-test (before intervention) and Post-test (after completion of intervention sessions). Method of measurement: This variable is recorded using a computerized Stroop task software, calculating reaction time (in milliseconds) and response accuracy separately for congruent and incongruent conditions.</sec_outcome>
      <sec_outcome>The severity of Oppositional Defiant Disorder (ODD) symptoms in participants is assessed using the Child Behavior Checklist (CBCL) or the ODD subscale. Lower post-test scores compared to pre-test scores indicate a reduction in oppositional and defiant behaviors. Timepoint: Pre-test and Post-test. Method of measurement: The measurement tool is the Child Behavior Checklist (CBCL) completed by parents. The ODD subscale score is used as the indicator of disorder severity.</sec_outcome>
      <sec_outcome>Participants’ ability to regulate their emotions is assessed using the Emotion Regulation Checklist (ERC). Higher ERC scores indicate improved ability to manage and modulate emotional responses. Timepoint: Pre-test and Post-test. Method of measurement: The ERC questionnaire is completed by parents and includes subscales of emotion regulation and emotional lability. The total average score is calculated for analysis.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-09-22</approval_date>
        <contact_name>Research Ethics Committees of Tehran Islamic Azad University Of Medical Sciences</contact_name>
        <contact_address>Central Administrative Building, Islamic Azad University of Medical Sciences – Tehran No. 16 West, Gol Yakh Gharbi St., Ayeneh Blvd., Shahid Pabarja St., Gholhak Crossroad, Shariati St., Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
